NASDAQ$MASI

Masimo Corp. · Q4 2024 earnings

Q4 2024 earnings · · After market close · Investor relations

Briefing

Masimo experienced revenue growth driven by healthcare segment performance.

Masimo reported a net loss of $349.6 million for Q4 2024 due to impairment charges related to Sound United. Revenue for the quarter increased by 9% year-over-year, driven by strong healthcare segment performance. Non-GAAP net income per diluted share grew by 44% compared to the prior year period.

  • Consolidated revenue grew 9% year-over-year to $601 million.
  • GAAP net loss of $349.6 million, driven by impairment charges.
  • Healthcare revenue grew 8% year-over-year to $368 million.
  • Non-GAAP net income per diluted share was $1.80, a 44% increase.

Headline financials

Total Revenue

$601M

Previous: $549M+9.5%
EPS (adj)

$1.80

Previous: $1.25+44.0%
Capital Expenditures

-$3M

Previous: -$25.3M+88.1%
Net Income

-$350M

Previous: $34M-1128.2%
Operating Income

-$359M

Previous: $44.1M-914.1%
Gross Profit

$245M

Previous: $263M-6.9%
R&D Expense

$77.7M

Previous: $38M+104.5%

Revenue & EPS history

Masimo · Revenue · Quarterly

$601M

Q4 2024+9.5%vs Q4 2023
Beat estimate in 9 of 14 quarters(64%)
ActualEstimate

Forward guidance

Masimo expects revenue growth and increased earnings for 2025, driven by strategic realignment and a focus on healthcare.

Tailwinds

  • Healthcare revenue expected to grow by 8% to 11% in 2025.
  • Increased focus on healthcare business following strategic realignment.
  • Non-GAAP earnings per share expected to increase to between $5.10 and $5.40.
  • Strong momentum in customer contracts.
  • One additional calendar week for healthcare business revenue in 2025.

Headwinds

  • Potential impact from new tariffs on products sourced from Mexico.
  • No revenue guidance provided for the non-healthcare segment.
  • Ongoing litigation-related expenses.
  • Potential impact from fluctuations in foreign currency exchange rates.
  • Cost pressures on healthcare product lines.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

-0.6%

Avg return

Earnings day

-0.1%

Avg return

5 days after

+1.6%

Avg return

30 days after

54%

35 / 65 earnings

Positive

+17.2%

Q2 2024

Best reaction

-35.8%

Q4 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.2%+0.1%+0.4%
Q4 2025+0.1%+7.4%+0.6%
Q3 2025-4.8%-3.0%-4.9%
Q1 2025-6.5%+1.3%+6.5%
Q4 2024+12.3%+12.4%-3.5%
Q3 2024+13.7%+10.2%+14.9%
Q2 2024+17.2%+21.1%+9.0%
Q1 2024-13.0%-11.8%-9.6%
Q4 2023-1.5%-3.2%+12.4%
Q3 2023+2.5%+6.6%+30.5%
Q2 2023-4.1%-7.6%-11.8%
Q1 2023-7.0%-8.0%-16.1%
Q4 2022+4.1%+7.9%+5.6%
Q3 2022-12.1%+3.1%+10.1%
Q2 2022+2.1%-0.2%-0.4%
Q1 2022+7.5%+8.5%+19.8%
Q4 2021-35.8%-31.3%-29.9%
Q3 2021+1.4%-0.7%+0.1%
Q2 2021-0.6%+2.3%+3.8%
Q1 2021-6.9%-5.5%-12.4%
Q4 2020+0.5%+0.3%-9.6%
Q3 2020-5.1%-9.0%-0.3%
Q2 2020-7.2%-6.6%-6.7%
Q1 2020-0.6%+1.7%+9.3%
Q4 2019+0.2%-4.5%-14.5%
Q3 2019-1.5%-2.2%+4.7%
Q2 2019-2.8%-7.8%-3.2%
Q1 2019-1.5%+1.1%-2.9%
Q4 2018+1.3%+3.9%+5.5%
Q3 2018-2.2%-3.3%-4.5%
Q2 2018+8.9%+9.1%+18.6%
Q1 2018+4.3%+7.6%+10.2%
Q4 2017+2.2%-1.4%+2.7%
Q3 2017+1.3%-1.0%+2.3%
Q2 2017-10.3%-10.8%-11.5%
Q1 2017-14.2%-17.0%-12.5%
Q4 2016+5.7%+11.1%+21.9%
Q3 2016+5.5%+10.7%+12.3%
Q2 2016+9.3%+6.1%+14.0%
Q1 2016+7.7%
Q4 2015+5.7%
Q3 2015+4.0%
Q2 2015+6.2%
Q1 2015+1.0%
Q4 2014+8.0%
Q3 2014+7.0%
Q2 2014-11.2%
Q1 2014-9.1%
Q4 2013-4.2%
Q3 2013-9.2%
Q2 2013+5.5%
Q1 2013+7.5%
Q4 2012-0.3%
Q3 2012-1.1%
Q2 2012-6.2%
Q1 2012-6.6%
Q4 2009-3.8%
Q4 2011-3.8%
Q3 2011+1.1%
Q2 2011-8.4%
Q1 2011+4.0%
Q3 2010+0.0%
Q2 2010+1.1%
Q4 2010+1.1%
Q1 2010+2.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro